As you may already know, there has been a statement issued by the FDA as a warning regarding the use of probiotics in premature infants. Our critical response team was activated immediately at the beginning of October. The team analyzed the situation and determined that at the time, there was not enough information to comment on. After the second warning letter that was released on October 26, the critical response team was now prepared to make a statement representing the association.
If you have any questions, we encourage you to use this statement and its content within your companies. We are grateful for this committee’s work on this statement.